MMP20
MMP17, also known as Matrix Metallopeptidase 17, is a member of the matrix metalloproteinase (MMP) family, which is involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis.
Structure[edit | edit source]
MMP17 is a membrane-type matrix metalloproteinase (MT-MMP), which means it is anchored to the cell membrane. It is characterized by a transmembrane domain that allows it to be localized on the cell surface. The protein is synthesized as an inactive zymogen and requires proteolytic cleavage for activation.
Function[edit | edit source]
MMP17 plays a crucial role in the activation of other MMPs, such as MMP2, by cleaving their propeptide domains. This activation is essential for the degradation of the extracellular matrix components, which is a critical step in cell migration, invasion, and tissue remodeling. MMP17 is also involved in the shedding of cell surface molecules, which can influence cell signaling and interaction.
Clinical Significance[edit | edit source]
MMP17 has been implicated in various pathological conditions, including cancer, where it may contribute to tumor progression and metastasis by facilitating the invasion of cancer cells through the extracellular matrix. It is also involved in inflammatory diseases and has been studied in the context of osteoarthritis and rheumatoid arthritis.
Regulation[edit | edit source]
The activity of MMP17 is tightly regulated at multiple levels, including gene expression, zymogen activation, and inhibition by tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMP17 activity can lead to excessive matrix degradation and is associated with various diseases.
Research Directions[edit | edit source]
Current research on MMP17 focuses on understanding its specific substrates and the pathways it influences. There is also interest in developing specific inhibitors that can modulate its activity for therapeutic purposes.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD